Kofinas Fertility

What Kofinas Fertility does

Kofinas Fertility Group is a New York City-based, founder-owned reproductive medicine practice founded in 1987 by Dr. George Kofinas. It operates as a horizontally-segmented fertility clinic serving individuals and couples across distinct use cases — couples and individuals with diagnosed or unexplained infertility, LGBTQ+ family-building patients, oncology patients requiring urgent fertility preservation, women/men seeking elective fertility preservation, and patients seeking second opinions after failed cycles elsewhere. Service delivery spans comprehensive diagnostic evaluation, IUI, IVF with ICSI and frozen embryo transfer, egg/embryo/sperm freezing, ovarian tissue cryopreservation, and a full suite of minimally invasive reproductive surgery (laparoscopy, hysteroscopy, myomectomy, cystectomy, adhesion lysis) performed at the group's 10,000-square-foot Manhattan Reproductive Surgery Center — the first fully licensed ambulatory surgical facility in New York State dedicated solely to reproductive care. Six in-house laboratories (embryology and tissue cryopreservation with 24/7 monitoring) underpin integrated surgical-ART workflows under a single clinical team.

The business is a fee-for-service clinical practice. Pricing is unit-based: IVF cycles list at $11,000-$12,000, egg freezing at roughly $10,000 per cycle, and IUI up to ~$2,000 per cycle, with insurance coverage depending on plan, employer, and state. New York's FAFTA mandate (effective January 2020, applicable to employers with 100+ employees) expanded IVF coverage in the firm's core market, and the practice has built insurance-navigation and financing infrastructure to capture insured volume. Go-to-market is direct-to-consumer augmented by a referring-physician network of 300+ OB/GYNs, supported by content marketing, patient testimonials, an online appointment request funnel, and a patient portal (eivf.kofinas.org). Distribution is regional, through five physical locations spanning Lower Manhattan (HQ + ASC), Upper West Side, Brooklyn, Staten Island, and Long Island (Roslyn Heights). The practice does not use resellers, intermediaries, or external capital — it is founder-controlled, with Dr. Kofinas serving as Medical Director and personally training all staff physicians.

Name

Kofinas Fertility

Legal name

Kofinas Fertility Group

Website

https://kofinasfertility.com

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

101–250 employees

Short description

Kofinas Fertility Group is a founder-owned, New York-based reproductive medicine practice offering integrated diagnostic evaluation, IVF, IUI, fertility preservation, and reproductive surgery across five locations and a dedicated ambulatory surgery center, serving individuals and couples facing infertility, LGBTQ+ family building, and oncology-related fertility preservation needs.

Ownership category

akta.pro rank

Product category

Reproductive Healthcare Services

NAICS

Family Planning Centers (621410)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industries

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Male Reproductive & Sexual Medicine (Andrology) (HLAKAOAD)

Keywords

• Fertility treatment services
• In vitro fertilization
• Fertility preservation
• Reproductive surgery
• Assisted reproductive technology

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Fertility Treatment Services: Revenue generated from comprehensive fertility treatments including IVF, IUI, egg freezing, embryo freezing, surgical procedures, male fertility treatment, and fertility preservation. Services are provided at multiple locations with in-house surgical facility.
2. Diagnostic and Consultation Services: Fertility assessments, comprehensive diagnostic testing, second opinion consultations, and treatment planning services.
3. Egg Donor Program: Egg donation program matching donors with infertile couples. Application process for prospective egg donors.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Kofinas Fertility Group provides comprehensive reproductive medicine services across five New York City-area clinic locations, offering a diagnostic-first care path that combines fertility assessment, reproductive surgery, and assisted reproductive technologies. Core services include IVF with ICSI, IUI with ovarian stimulation, egg/embryo/sperm freezing, ovarian tissue cryopreservation, LGBTQ+ family building, and donor/surrogacy programs. Treatment is supported by six in-house laboratories and a dedicated ambulatory surgery center, with all clinical services performed by a team of board-certified reproductive endocrinologists personally trained by the founder.

Product overview

Kofinas Fertility Group is a comprehensive fertility clinic offering a unified platform of fertility services across five New York City locations. The core offering centers on diagnostic evaluation and personalized treatment planning, with a full spectrum of reproductive technologies including IUI, IVF with ICSI and FET, egg/embryo/sperm freezing, and ovarian tissue cryopreservation. Surgical services encompass laparoscopic procedures, hysteroscopy, and myomectomy delivered through the Manhattan Reproductive Surgery Center. The practice differentiates through its integrated approach combining fertility therapies, reproductive surgery, and IVF lab services under one roof, with services spanning LGBTQ+ family building, donor programs, surrogacy, and cancer fertility preservation.

Differentiator

Problem solved

Functional benefit

Products and services

• In Vitro Fertilization (IVF)

Quantifiable outcome

• IVF success rates: >35 years: 60.0%; 35-37 years: 46.8%; 38-40 years: 35.1%; >40 years: 8.9% (CDC data)
• +3 more outcomes

Named customers12 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators7 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• RMA of New York: Reproductive Medicine Associates of New York is the largest direct competitor in the NYC metro, offering IVF, ICSI, egg freezing, PGT, and LGBTQ+ family building across multiple Manhattan locations with comparable physician-led clinical depth.
• New Hope Fertility Center: New York City-based fertility clinic offering IVF, IUI, egg freezing, and Mini-IVF protocols, directly competing for the same metropolitan patient base with a similar full-service specialty positioning.
• NYU Langone Fertility Center: Academic fertility program in Manhattan providing IVF, egg freezing, and reproductive surgery as part of NYU Langone, competing for the same diagnostic-first and complex case referrals in the New York market.
• Columbia University Fertility Center: Academic medical center-based reproductive endocrinology and fertility program in NYC offering IVF, IUI, fertility preservation, and LGBTQ+ family building with a similarly integrated diagnostic and surgical approach.
• Weill Cornell Medicine - Reproductive Medicine: Academic REI program at Weill Cornell offering IVF, IUI, egg/embryo freezing, and reproductive surgery within a New York-based hospital system, drawing from the same physician referral network and patient catchment.

Broad incumbents

• CCRM Fertility: Large multi-state fertility network with industry-leading IVF lab technology and high published success rates, including NYC-area locations; operates as a broader incumbent with significant marketing and capital scale advantages.
• Boston IVF: One of the largest US fertility networks with multi-state clinical footprint and a full suite of ART and andrology services, providing broad-incumbent scale comparable in service mix to Kofinas.
• Shady Grove Fertility: Large national fertility network offering IVF, donor services, and shared-risk programs across the eastern US, representing the broad-incumbent operating model that founder-led practices increasingly compete against.

Emerging players

• Kindbody: Tech-enabled, venture-backed fertility and gynecology platform with growing NYC-area presence, employer-benefit partnerships, and lower-cost positioning; represents the emerging, capital-rich model pressuring independent clinics.
• Extend Fertility: Specialized egg freezing clinic with NYC locations focused narrowly on fertility preservation — overlapping with a meaningful segment of Kofinas' service mix but with a more concentrated, modern consumer brand.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kofinas Fertility